Best Transarterial Radioembolization- TARE Treatment Hospitals Worldwide

Aster DM Healthcare offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1987, the JCI, NABH, NABL hospital is located in Dubai, United Arab Emirates and has 114 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Medipol Bahçelievler Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2022, the JCI hospital is situated in Istanbul, Turkey and has 441 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Medanta - The Medicity offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2009, the JCI, NABH hospital is located in Gurgaon, India and has 1250 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Phyathai 2 International Hospital offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1987, the JCI hospital is located in Bangkok, Thailand and has 550 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

At ParkCity Medical Centre, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 2012, this JCI hospital in Kuala Lumpur, Malaysia has 300 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Choosing Florence Nightingale Hospital for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1989, the JCI hospital in Istanbul, Turkey has 804 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Parkway East Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1942, the JCI hospital is situated in Singapore, Singapore and has 143 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Krabi Nakharin International Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1997, the JCI hospital is situated in Krabi, Thailand and has 150 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Gleneagles Hospital Mumbai offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1996, the JCI hospital is located in Mumbai, India and has 450 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

At Subang Jaya Medical Centre, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1985, this JCI hospital in Kuala Lumpur, Malaysia has 442 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Saudi German Hospital provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 2012, the JCI hospital is located in Dubai, United Arab Emirates, and operates 300 beds, equipped with modern healthcare infrastructure.

Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.

Yanhee International Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1984, the ISO, JCI hospital is situated in Bangkok, Thailand and has 400 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Choosing Antalya Anadolu Hastanesi for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 2006, the hospital in Antalya, Turkey has 114 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Max Super Specialty Hospital, Vaishali offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2008, the NABL, NABH hospital is located in Ghaziabad, India and has 370 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Canadian Specialist Hospital offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI hospital is located in Dubai, United Arab Emirates and has 200 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.